Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation.

Our expertise and capabilities are centered around the development of value-added generic drugslife cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development’ as not just offering a technical solution but always part of a broader product-oriented strategy. Welcome to Avivia and we hope to be in touch soon!


Transistorweg 5 ( Building M)

6534 AT Nijmegen

The Netherlands

+31 (0)6 1968 6732


More companies in this area

Pleco Therapeutics

Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer.

GCP-Service International

GCP-Service International is a mid-size contract research organization (CRO), with branches across Germany, Netherlands, Poland and Czech Republic.

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,


Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.


TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!